Investing For Growth

What You'll Find Here | The IFG Approach Explained | The IFG Statistics Center
Friday, June 28, 1996
The Daily IFG Report (FOOL GLOBAL WIRE) by Robert Sheard (MF DowMan) LEXINGTON, Ky. (June 28): After almost disappearing into red ink earlier this week, the Classic IFG Model for 1996 has rebounded considerably yesterday and today, actually outperforming all three indices for the second quarter of 1996. With a year-to-date return of 7.3%, the model is still underwhelming for 1996, and still lagging considerably its long-term average of 26% a year, but recent signs of life are showing. And for those of you following the relative strength models we began tracking this year, the performance has been much more inspired. The quarterly model is up 21.9% at the year's mid-point while the monthly model is up 26.4%. (For more details on these models, visit the IFG Statistics Center this weekend.) In stock news, Tellabs <% if gsSubBrand = "aolsnapshot" then Response.Write("(NASDAQ:TLAB)") else Response.Write("(NASDAQ:TLAB)") end if %> continues its strong run as analysts are starting to hint that they suspect an earnings surprise when the company reports results on July 8. The current estimate is for $0.38 a share. Medtronic <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:MDT)") else Response.Write("(NYSE:MDT)") end if %> was in the news again today, announcing that it's completed the merger with InStent <% if gsSubBrand = "aolsnapshot" then Response.Write("(NASDAQ:ININ)") else Response.Write("(NASDAQ:ININ)") end if %>. InStent makes self-expanding and baloon-expandable stents which are used in medical procedures throughout the body. The terms of the merger call for Medtronic to exchange 0.3833 share of its stock for each of the approximately 10 million InStent shares, plus options outstanding. The total deal is worth about $200 million. Medtronic also announced yesterday that is has entered into a worldwide exclusive joint research and development agreement with Regeneron Pharmaceuticals Inc to collaborate on a family of therapeutics for central nervous system diseases and disorders. These will make use of experimental Regeneron compounds and Medtronic delivery systems, with the initial target being a potential treatment of Huntington's disease. Have a Foolish Weekend! Transmitted: 6/28/96	The Current IFG Stocks RoTech Medical <% if gsSubBrand = "aolsnapshot" then Response.Write("(NASDAQ:ROTC)") else Response.Write("(NASDAQ:ROTC)") end if %> Paychex <% if gsSubBrand = "aolsnapshot" then Response.Write("(NASDAQ:PAYX)") else Response.Write("(NASDAQ:PAYX)") end if %> Green Tree Financial <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:GNT)") else Response.Write("(NYSE:GNT)") end if %> Tellabs <% if gsSubBrand = "aolsnapshot" then Response.Write("(NASDAQ:TLAB)") else Response.Write("(NASDAQ:TLAB)") end if %> Quick & Reilly Group <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:BQR)") else Response.Write("(NYSE:BQR)") end if %> Mirage Resorts <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:MIR)") else Response.Write("(NYSE:MIR)") end if %> Checkpoint Systems <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:CKP)") else Response.Write("(NYSE:CKP)") end if %> Dionex <% if gsSubBrand = "aolsnapshot" then Response.Write("(NASDAQ:DNEX)") else Response.Write("(NASDAQ:DNEX)") end if %> Three Com <% if gsSubBrand = "aolsnapshot" then Response.Write("(NASDAQ:COMS)") else Response.Write("(NASDAQ:COMS)") end if %> Hewlett-Packard <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:HWP)") else Response.Write("(NYSE:HWP)") end if %>
Today's IFG Numbers INVESTING FOR GROWTH MODEL (6/28/96) Day Week Quarter Year History IFG 2.09% 2.40% 7.87% 7.31% 4265.83% DJIA -0.40% -0.89% 1.21% 10.50% 582.23% S&P 500 0.31% 0.57% 3.89% 8.88% 529.58% NASDAQ 1.63% 0.83% 7.60% 12.63% 700.58% Rec'd # Security In At Now Change 7/8/95 3866 TLAB 48.00 66.88 39.32% 1/5/96 6252 ORCL 28.58 39.44 37.97% 4/5/96 7695 CKP 26.75 34.38 28.50% 1/5/96 3183 CA 56.13 71.00 26.50% 4/5/96 6804 BIO/A 30.25 35.88 18.60% 4/5/96 10624 ROTC 19.38 19.50 0.65% 4/5/96 3525 MDT 58.38 56.00 -4.07% 4/5/96 5945 GNT 34.63 31.25 -9.75% 4/5/96 5758 DNEX 35.75 32.25 -9.79% 4/5/96 3293 UNH 62.50 50.50 -19.20% Rec'd # Security Cost Value Change 7/8/95 3866 TLAB $185,568.00 $258,538.75 $72,970.75 1/5/96 6252 ORCL $178,703.00 $246,563.25 $67,860.25 4/5/96 7695 CKP $205,841.25 $264,515.63 $58,674.38 1/5/96 3183 CA $178,645.88 $225,993.00 $47,347.13 4/5/96 6804 BIO/A $205,821.00 $244,093.50 $38,272.50 4/5/96 10624 ROTC $205,840.00 $207,168.00 $1,328.00 4/5/96 3525 MDT $205,771.88 $197,400.00 $(8,371.88) 4/5/96 5945 GNT $205,845.63 $185,781.25 $(20,064.38) 4/5/96 5758 DNEX $205,848.50 $185,695.50 $(20,153.00) 4/5/96 3293 UNH $205,812.50 $166,296.50 $(39,516.00) CASH $868.81 TOTAL $2,182,914.19 Transmitted: 6/28/96
Main Page Fools & Their Money Hall of Portfolios Investing Foolishly Daily News Stock Research Foolish Games
Copyright © 1996 The Motley Fool, Inc. All Rights Reserved.